Partial beta 2-agonists and their impartial assessment.
B F
BF
Dickey
R C
RC
Clark
R
R
Barber
D000280:Administration, Inhalation; D058665:Adrenergic beta-1 Receptor Agonists; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy / Q000503:physiopathology; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D018342:Receptors, Adrenergic, beta-1 / Q000187:drug effects / Q000648:ultrastructure; D015398:Signal Transduction / Q000187:drug effects
D058665:Adrenergic beta-1 Receptor Agonists; D000318:Adrenergic beta-Agonists; D018927:Anti-Asthmatic Agents; D001993:Bronchodilator Agents; D018342:Receptors, Adrenergic, beta-1